BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24028901)

  • 21. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome in obese Thai children and adolescents.
    Iamopas O; Chongviriyaphan N; Suthutvoravut U
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.
    Paragh G; Seres I; Harangi M; Erdei A; Audikovszky M; Debreczeni L; Kovácsay A; Illyés L; Pados G
    Br J Clin Pharmacol; 2006 Jun; 61(6):694-701. PubMed ID: 16722831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes.
    Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD
    Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
    Hung J; McQuillan BM; Thompson PL; Beilby JP
    Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome.
    Mackness B; Quarck R; Verreth W; Mackness M; Holvoet P
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1545-50. PubMed ID: 16627808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omega-3 polyunsaturated fatty acids reduce insulin resistance and triglycerides in obese children and adolescents.
    Juárez-López C; Klünder-Klünder M; Madrigal-Azcárate A; Flores-Huerta S
    Pediatr Diabetes; 2013 Aug; 14(5):377-83. PubMed ID: 23438101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
    Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of the antioxidant enzyme paraoxonase in Argentinean children living at high altitude.
    Hirschler V; Martín M; Oestreicher K; Molinari C; Tetzlaff W; Botta E; Boero L; Brites F;
    Redox Rep; 2018 Dec; 23(1):35-40. PubMed ID: 28853330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women.
    Cervellati C; Bonaccorsi G; Trentini A; Valacchi G; Sanz JM; Squerzanti M; Spagnolo M; Massari L; Crivellari I; Greco P; Parladori R; Passaro A; Ricci G
    Scand J Clin Lab Invest; 2018; 78(1-2):18-24. PubMed ID: 29168398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain.
    Garcés C; López-Simón L; Rubio R; Benavente M; Cano B; Ortega H; de Oya M
    Clin Chem Lab Med; 2008; 46(6):809-13. PubMed ID: 18601602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma levels of adiponectin and tumor necrosis factor-alpha in children with obesity].
    Yan WJ; Wu J; Mo J; Huang CW; Peng LW; Xu L
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):47-50. PubMed ID: 19149923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity, plasma high sensitivity C-reactive protein levels and insulin resistance status among school children in Taiwan.
    Wu DM; Chu NF; Shen MH; Wang SC
    Clin Biochem; 2006 Aug; 39(8):810-5. PubMed ID: 16814764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index.
    Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):592-9. PubMed ID: 18465683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes.
    Utzschneider KM; Van de Lagemaat A; Faulenbach MV; Goedecke JH; Carr DB; Boyko EJ; Fujimoto WY; Kahn SE
    Obesity (Silver Spring); 2010 Sep; 18(9):1781-7. PubMed ID: 20379148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
    Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
    Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto M; Fontana L; Castaldo M; Bonaiuto A; Saitta C; Bitto A; Manduca B; Riggio S; Saitta A
    Exp Gerontol; 2004 Jul; 39(7):1089-94. PubMed ID: 15236768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender related differences in paraoxonase 1 response to high-fat diet-induced oxidative stress.
    Thomàs-Moyà E; Gómez-Pérez Y; Fiol M; Gianotti M; Lladó I; Proenza AM
    Obesity (Silver Spring); 2008 Oct; 16(10):2232-8. PubMed ID: 18719679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.